On November 16, the Guangdong Provincial Price Bureau issued the “Circular on Announcement of the Highest Temporary Retail Prices for the Central Purchasing of Drugs by Medical Institutions in Guangdong Province in 2010â€, stating that in order to implement the spirit of the “Notice of Implementing the “Three Controls†Management of Drug Pricesâ€, The Guangdong Province decided to adjust the prices of 4,231 government-priced pharmaceuticals that were originally announced for centralized procurement by Guangdong medical institutions in 2010.
According to reports, the prices of other unlisted pharmaceutical dosage forms are still subject to the "Notice on Announcement of the 2010 Maximum Provisional Retail Price for Medicinal Products Purchased by Medical Institutions in Guangdong Province." Medical institutions that implement zero-dose trials of drugs are sold at purchase prices. In Zhanjiang City and Shaoguan City, pilot medical institutions that tried to reform the rate of increase of drug prices may not implement the difference rate (amount) of medical institutions that is stipulated in the "Notice on Implementing the "Three Controls" Management of Drug Prices." The Guangdong Provincial Price Bureau said that at present, only the maximum retail price of these drugs is limited, and in the future, the actual supply price and the circulation difference rate will also be managed.
The reporter saw from the limit table that the maximum retail price of aloxicillin injection 10/box was 77.47 yuan, the purchase price was adjusted to 67.70 yuan, the highest retail price of azithromycin injection 10/box was 124.33 yuan, and the adjusted purchase price was 110.30 yuan and so on, in general, the purchase price fell by an average of about 10% from the highest retail price. The Guangdong Provincial Price Bureau stated that the drugs sold within the province that belong to the scope of government price management are changed from “one control†that focuses on retail prices to more stringent “three controlsâ€. This drug price control method starts from the original circulation link. The change of regulation is monitored from the perspective of the total cost of the process, such as fees and taxes, which is a new exploration of drug price reform. All medical institutions and related enterprises shall strictly implement the provisions of the "three-control" management of drug prices. If the relevant policies are not implemented, the competent pricing department shall follow laws such as the "Price Law" and "Provisions on Administrative Penalties for Price Violations." Investigate and deal with laws and regulations and expose typical cases.
According to reports, the prices of other unlisted pharmaceutical dosage forms are still subject to the "Notice on Announcement of the 2010 Maximum Provisional Retail Price for Medicinal Products Purchased by Medical Institutions in Guangdong Province." Medical institutions that implement zero-dose trials of drugs are sold at purchase prices. In Zhanjiang City and Shaoguan City, pilot medical institutions that tried to reform the rate of increase of drug prices may not implement the difference rate (amount) of medical institutions that is stipulated in the "Notice on Implementing the "Three Controls" Management of Drug Prices." The Guangdong Provincial Price Bureau said that at present, only the maximum retail price of these drugs is limited, and in the future, the actual supply price and the circulation difference rate will also be managed.
The reporter saw from the limit table that the maximum retail price of aloxicillin injection 10/box was 77.47 yuan, the purchase price was adjusted to 67.70 yuan, the highest retail price of azithromycin injection 10/box was 124.33 yuan, and the adjusted purchase price was 110.30 yuan and so on, in general, the purchase price fell by an average of about 10% from the highest retail price. The Guangdong Provincial Price Bureau stated that the drugs sold within the province that belong to the scope of government price management are changed from “one control†that focuses on retail prices to more stringent “three controlsâ€. This drug price control method starts from the original circulation link. The change of regulation is monitored from the perspective of the total cost of the process, such as fees and taxes, which is a new exploration of drug price reform. All medical institutions and related enterprises shall strictly implement the provisions of the "three-control" management of drug prices. If the relevant policies are not implemented, the competent pricing department shall follow laws such as the "Price Law" and "Provisions on Administrative Penalties for Price Violations." Investigate and deal with laws and regulations and expose typical cases.
Root Canal Motor,Dental Endo Motor,Wireless Endo Motor,Dental Root Canal Endo Motor
Hebi Tianchi Trading Co., Ltd , https://www.hebitianchi.com